Effects of aging on isoflurane-induced and protein kinase a-mediated activation of atp-sensitive potassium channels in cultured rat aortic vascular smooth muscle cells

Journal of Cardiovascular Pharmacology

Volumn 56, Issue 6, 2010, Pages 676-685

  Kawano, Takashi ^a   Tanaka, Katsuya ^b   Chi, Haidong ^a   Kimura, Masakazu ^c   Kawano, Hiroaki ^b   Eguchi, Satoru ^a   Oshita, Shuzo ^b  

^a KOCHI MEDICAL SCHOOL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

^c Sakaide Kaisei Hospital   (Japan)

Author keywords

Aging; Anesthetics; Patch clamp configurations; Potassium channel; Protein kinase

Indexed keywords

ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; CYCLIC AMP DEPENDENT PROTEIN KINASE; FORSKOLIN; ISOFLURANE; PINACIDIL;

AGED; AGING; ANIMAL CELL; ARTICLE; CELL CULTURE; MALE; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE FIBER; VASCULAR SMOOTH MUSCLE;

AGING; ANIMALS; AORTA; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; ISOFLURANE; KATP CHANNELS; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; RATS; RATS, WISTAR;

EID: 78751642341     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/FJC.0b013e3181fc4671     Document Type: Article

References (40)

1. Jahangir A, Sagar S, Terzic A. Aging and cardioprotection. J Appl Physiol. 2007;103:2120-2128.
2. Boersma E, Pieper KS, Steyerberg EW, et al. Predictors of outcome in patients with acute coronary syndromes without persistent ST-segment elevation. Results from an international trial of 9461 patients. The PURSUIT Investigators. Circulation. 2000;101:2557-2567.
3. Maggioni A, Maseri A, Fresco C, et al. Age-related increase in mortality among patients with first myocardial infarctions treated with thrombolysis. N Engl J Med. 1993;329:1442-1448.
4. Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986; 74:1124-1136.
5. Fenton RA, Dickson EW, Meyer TE, et al. Aging reduces the cardioprotective effect of ischemic preconditioning in the rat heart. J Mol Cell Cardiol. 2000;32:1371-1375.
6. Schulman D, Latchman DS, Yellon DM. Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol. 2001;281:H1630-H1636.
7. Lee TM, Su SF, Chou TF, et al. Loss of preconditioning by attenuated activation of myocardial ATP-sensitive potassium channels in elderly patients undergoing coronary angioplasty. Circulation. 2002;105: 334-340.
8. Kersten JR, Schmeling TJ, Pagel PS, et al. Isoflurane mimics ischemic preconditioning via activation of KATP channels: reduction of myocardial infarct size with an acute memory phase. Anesthesiology. 1997;87: 361-370.
9. Toller WG, Gross ER, Kersten JR, et al. Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology. 2000;92: 1731-1739.
10. Tanaka K, Weihrauch D, Kehl F, et al. Mechanism of preconditioning by isoflurane in rabbits: a direct role for reactive oxygen species. Anesthesiology. 2002;97:1485-1490.
11. Tanaka K, Ludwig LM, Kersten JR, et al. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology. 2004;100:707-721.
12. Mio Y, Bienengraeber MW, Marinovic J, et al. Age-related attenuation of isoflurane preconditioning in human atrial cardiomyocytes: roles for mitochondrial respiration and sarcolemmal adenosine triphosphatesensitive potassium channel activity. Anesthesiology. 2008;108: 612-620.
13. Riess ML, Camara AK, Rhodes SS, et al. Increasing heart size and age attenuate anesthetic preconditioning in guinea pig isolated hearts. Anesth Analg. 2005;101:1572-1576.
14. Flagg TP, Enkvetchakul D, Koster JC, et al. Muscle KATP channels: recent insights to energy sensing and myoprotection. Physiol Rev. 2010;90: 799-829.
15. Yokoshiki H, Sunagawa M, Seki T, et al. ATP-sensitive K+ channels in pancreatic, cardiac, and vascular smooth muscle cells. Am J Physiol. 1998;274:C25-C37.
16. Ballanyi K. Protective role of neuronal KATP channels in brain hypoxia. J Exp Biol. 2004;207:3201-3212.
17. Kawano T, Zoga V, McCallum JB, et al. ATP-sensitive potassium currents in rat primary afferent neurons: biophysical, pharmacological properties, and alterations by painful nerve injury. Neuroscience. 2009;162: 431-343.
18. Miki T, Suzuki M, Shibasaki T, et al. Mouse model of Prinzmetal angina by disruption of the inward rectifier Kir6.1. Nat Med. 2002;8: 466-472.
19. Chutkow WA, Pu J, Wheeler MT, et al. Episodic coronary artery vasospasm and hypertension develop in the absence of Sur2 KATP channels. J Clin Invest. 2002;110:203-208.
20. Crystal GJ, Gurevicius J, Ramez Salem M, et al. Role of adenosine triphosphate-sensitive potassium channels in coronary vasodilation by halothane, isoflurane and enflurane. Anesthesiology. 1997;86:448-458.
21. Zhou X, Abboud W, Manabat NC, et al. Isoflurane-induced dilation of porcine coronary arterioles is mediated by ATP-sensitive potassium channels. Anesthesiology. 1998;89:182-189.
22. Tanaka K, Kawano T, Nakamura A, et al. Isoflurane activates sarcolemmal adenosine triphosphate-sensitive potassium channels in vascular smooth muscle cells: a role for protein kinase A. Anesthesiology. 2007;106: 984-991.
23. Kawano T, Oshita S, Takahashi A, et al. Molecular mechanisms underlying ketamine-mediated inhibition of sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology. 2005;102: 93-101.
24. Kawano T, Oshita S, Takahashi A, et al. Molecular mechanisms of the inhibitory effects of bupivacaine, levobupivacaine, and repivacaine on sarcolemmal adenosine triphosphate-sensitive potassium channels in the cardiovascular system. Anesthesiology. 2004;101:390-398.
25. Kawano T, Oshita S, Takahashi A, et al. Molecular mechanisms of the inhibitory effects of propofol and thiamylal on sarcolemmal adenosine triphosphate-sensitive potassium channels. Anesthesiology. 2004;100: 338-346.
26. Gertzberg N, Clements R, Jaspers I, et al. Tumor necrosis factor-alphainduced activating protein-1 activity is modulated by nitric oxidemediated protein kinase G activation. Am J Respir Cell Mol Biol. 2000;22: 105-115.
27. Babenko AP, Aguilar-Bryan L, Bryan J. A view of sur/KIR6.X, KATP channels. Annu Rev Physiol. 1998;60:667-687.
28. Quayle JM, Nelson MT, Standen NB. ATP-sensitive and inwardly rectifying potassium channels in smooth muscle. Physiol Rev. 1997;77: 1165-1232.
29. Brayden JE. Functional roles of KATP channels in vascular smooth muscle. Clin Exp Pharmacol Physiol. 2002;29:312-316.
30. Teramoto N. Physiological roles of ATP-sensitive K+ channels in smooth muscle. J Physiol. 2006;572:617-624.
31. Despeyroux S, Beaudu-Lange C, Coles JA, et al. Selective downregulation of an inactivating K+ conductance by analogues of cAMP in mouse Schwann cells. J Physiol. 1997;499:655-660.
32. Toyoda K, Fujii K, Takata Y, et al. Age-related changes in response of brain stem vessels to opening of ATP-sensitive potassium channels. Stroke. 1997;28:171-175.
33. Garnier-Raveaud S, Faury G, Mazenot C, et al. Highly protective effects of chronic oral administration of nicorandil on the heart of aged rats. Clin Exp Pharmacol Physiol. 2002;29:441-448.
34. Liu J, Long C, Ji B, et al. Myocardial protective effects of nicorandil, an opener of potassium channels on senile rat heart. Perfusion. 2006;21: 179-183.
35. Sandhu SK, Bhardwaj SK, Shrma P, et al. Alterations in signal transduction cascade in young and adult rat brain and lymphocytes. Brain Res Bull. 2001;54:513-520.
36. Headrick JP. Aging impairs functional, metabolic and ionic recovery from ischemia-reperfusion and hypoxia-reoxygenation. J Mol Cell Cardiol. 1998;30:1415-1430.
37. Headrick JP, Willems L, Ashton KJ, et al. Ischemic tolerance in aged mouse myocardium: the role of adenosine and effects of A1 adenosine receptor overexpression. J Physiol. 2003;549:823-833.
38. Lakatta EG, Mitchell JH, Pomerance A, et al. Human aging: changes in structure and function. J Am Coll Cardiol. 1987;10:42A-47A.
39. Roberts WC. The aging heart. Mayo Clin Proc. 1988;63:205-206.
40. Peart JN, Gross ER, Headrick JP, et al. Impaired p38 MAPK/HSP27 signaling underlies aging-related failure in opioid-mediated cardioprotection. J Mol Cell Cardiol. 2007;42:972-980.